Antabio SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Antabio SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10628
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Antabio SAS (Antabio) is a biopharmaceutical company that develops novel antibacterials targeting drug-resistant pathogens. The company’s pipeline products comprise Metallo Beta-Lactamases inhibitors, Pseudomonas Biofilms inhibitors and others. It uses in vitro technologies and bacterial disease know-how for the development of next generation antibacterial drugs targeting severe and difficult-to-treat infections caused by multi-drug resistant gram-negative pathogens. Antabio’s therapies provide treatment of medical needs of the antibacterial space and to address infections caused by pathogens. It also acquires additional assets on gram-negative antibiotic resistant therapies. Antabio is headquartered in Labege, France.

Antabio SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antabio SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antabio SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antabio SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Antabio Raises Additional USD6.1 Million in Series A Venture Financing 10
Antabio Raises USD8.6 Million in Series A Financing 11
Antabio Raises US$1 Million In Venture Financing 12
Antabio Raises USD0.4 Million in Seed Financing 13
Partnerships 14
Charles River Labs Enters into Agreement with Antabio 14
Argenta Discovery Enters Into Drug Discovery Agreement With Antabio 15
Antabio SAS – Key Competitors 16
Antabio SAS – Key Employees 17
Antabio SAS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Clinical Trials 19
Jul 25, 2017: ANTABIO Awarded Up to $8.9M from CARB-X to Accelerate the Development of its New Treatment for Chronic Infections in Cystic Fibrosis Patients 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Antabio SAS, Pharmaceuticals & Healthcare, Key Facts 2
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antabio SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antabio SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Antabio SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antabio Raises Additional USD6.1 Million in Series A Venture Financing 10
Antabio Raises USD8.6 Million in Series A Financing 11
Antabio Raises US$1 Million In Venture Financing 12
Antabio Raises USD0.4 Million in Seed Financing 13
Charles River Labs Enters into Agreement with Antabio 14
Argenta Discovery Enters Into Drug Discovery Agreement With Antabio 15
Antabio SAS, Key Competitors 16
Antabio SAS, Key Employees 17

List of Figures
Antabio SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antabio SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antabio SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Antabio SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • General Electric Capital Corporation:戦略・SWOT・企業財務分析
    General Electric Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary General Electric Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Recordati S.p.A.:企業のM&A・事業提携・投資動向
    Recordati S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recordati S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • ABITEC Corp:企業の戦略的SWOT分析
    ABITEC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sonatrach SPA-石油・ガス分野:企業M&A・提携分析
    Summary Sonatrach SPA (Sonatrach) is a state-owned integrated oil and gas company. Its businesses include exploration and production; pipeline transportation; liquefaction, refining and petrochemicals; marketing of petroleum products; maritime transportation; and other services. The company explores …
  • Tomra Systems ASA (TOM):企業の財務・戦略的SWOT分析
    Summary Tomra Systems ASA (Tomra Systems) is a logistics company that offers collection and sorting solutions. The company offers products such as managing tools, process analytics equipment, food processing lines, sorting systems, raw materials, raw material sorting equipment, and other specialty p …
  • CIMB Group Holdings Bhd:企業の戦略・SWOT・財務情報
    CIMB Group Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PT Telekomunikasi Indonesia, Tbk:企業の戦略・SWOT・財務情報
    PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Rox Resources Limited:企業の戦略・SWOT・財務情報
    Rox Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Rox Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Arthur J. Gallagher & Co:企業のM&A・事業提携・投資動向
    Arthur J. Gallagher & Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arthur J. Gallagher & Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Questor Technology Inc (QST):企業の財務・戦略的SWOT分析
    Questor Technology Inc (QST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Illinois Tool Works Inc.:企業のM&A・事業提携・投資動向
    Illinois Tool Works Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illinois Tool Works Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • PerkinElmer Inc (PKI):医療機器:M&Aディール及び事業提携情報
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagen …
  • Daicel Corp (4202)
    Daicel Corp (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stiefel Laboratories Inc (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a healthcare products provider that develops products for sun care, dry skin and clear skin. The company also offers research and development, manufacture, marketing and distribution of prescription medic …
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ABX Air, Inc.:企業の戦略的SWOT分析
    ABX Air, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Samyang Holdings Corp (000070):企業の財務・戦略的SWOT分析
    Summary Samyang Holdings Corp (Samyang) is a holding company engaged in the development and manufacture of food, pharmaceutical and chemical products. The company produces chemicals such as terephthalic acid, engineering plastics, organic chemicals, resins and other specialty chemicals; food materia …
  • Rengo Co Ltd:企業の戦略・SWOT・財務分析
    Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆